|
Post by aqt on Aug 25, 2009 14:53:34 GMT -5
www.carnicom.com/blood1.htmARTIFICIAL BLOOD (?) Clifford E Carnicom Aug 23 2009 This page is in progress and is subject to further revision. My time available for authoring is limited but the essentials of the findings and methods will be presented as time and circumstances permit. I am not offering any medical advice or diagnosis with the presentation of this information. I am acting solely as an independent researcher providing the results of extended observation and analysis of unusual biological conditions that are evident. Strong evidence now exists that an artificial or modified blood form is a dominant internal component, if not the dominant component, of dental filament samples that are commonly associated with the Morgellons condition. A method has been developed that breaks down the external casing of the fibers. A reconstitution process then takes place. The constituents in the resulting solution have been repeatedly examined under the microscope at high power. The method has been replicated numerous times, and on each occasion the same identifiable structures result. The structures indicate that they are a form of erythrocyte, or red blood cell. It has been repeatedly proposed by this researcher that the condition of the blood appears to be a common denominator of the Morgellons condition; this latest research further substantiates that position. All individuals tested thus far demonstrate these same blood variations, regardless of whether certain skin anomalies are present or not. It has previously been established that cultures developed from the dental samples are also producing erythrocytes, or red blood cells within the culture. This work has been confirmed with two separate forensic level tests. The latest finding of an erythrocytic form directly within original dental filament samples further substantiates this unique aspect of the Morgelllons condition. The biology of both the culture samples and the erythrocytic forms directly within the filaments is clearly outside the conventional framework of scientific knowledge, and it demonstrates advanced technologies that are beyond public purview and consent. These technologies likely include artificial or modified biological developments, advanced stem cell developments and genetic transfer or programming. The supposition that the eythrocytic forms are likely artificial, or at least manipulated in some fashion, is based upon the following observations: 1. The cells are essentially perfectly formed, with no visible variation in form or geometry. 2. Reconstitution of the erythrocytes takes place in an extremely hostile environment with respect to chemicals and heat. 3. An additional sub-micron structure often accompanies, or is within the erythrocytic form. These structures are identical by view and size to numerous anomalous human blood samples that have been reported on in conjunction with the Morgellons research through this site. 4. The size of the erythrocytic form within the dental filament varies more than within the human species, and this appears to be a response to the reconstitutive chemical environment. This chemical medium is hostile and adverse to normal biological development, but reconstitution appears to thrive in this same environment.
|
|
|
Post by aqt on Aug 25, 2009 14:57:54 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 14:58:26 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 14:58:57 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 14:59:29 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 15:00:41 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 15:15:17 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 16:41:43 GMT -5
Apparently, they have been throwing the notion around since 1956... this whole artificial blood "thing". "You've come a long way baby"....and I ain't talkin Virginia Slims..no sir. Pioneering artificial blood Thomas Ming Swi Chang is director of the Artificial Cells & Organs Research Centre (ACORC) and professor of physiology, medicine, and biomedical engineering at McGill University. While attending McGill University in 1956 as an undergraduate student, Chang had a vision to design the first artificial blood cell. He used only a cheap perfume atomiser, some collodion, and hemoglobin borrowed from a lab. Although his research project was considered by his peers to be far-fetched and fanciful, his work eventually gained international recognition and spawned a multibillion dollar industry in artificial cells and organs research. Progress in this field was accelerated by the realization that infection was transmissible through blood with such notable examples as the HIV epidemic in the 1980s and the tainted blood tragedy of the 1990s. Needless to say, many biomedical researchers have since embraced Chang's artificial cellular-based approach to carry hemoglobin through the body, and companies are presently conducting clinical trials with blood substitutes. www.entrepreneur.com/tradejournals/article/157588720.html
|
|
|
Post by aqt on Aug 25, 2009 16:44:42 GMT -5
Ideally, artificial blood should: * be capable of transporting and releasing oxygen under normal physiological conditions; * lack red blood cell membranes and surface antigens to avoid blood-type cross-matching; * be free of disease either through sterilization methods or through animal-free production methods such as recombinant protein production in E. coli or yeast; * be capable of being stored indefinitely at room temperature so that it can be stockpiled for war and disasters. Three current approaches in the research and development of artificial blood are modified hemoglobin, perfluorinated compounds, and transgenic hemoglobin. 1. Modified hemoglobin Pure hemoglobin cannot be used as artificial blood because it dissociates into a toxic dimer that is quickly filtered out by the kidneys. This can be prevented either through encapsulating or cross-linking the hemoglobin molecule. Encapsulated hemoglobin is an artificial red blood cell composed of a synthetic membrane containing hemoglobin. Since the membrane doesn't contain blood group antigens, there are no rejection or aggregation problems when introduced into the circulation. Chang first explored the concept of creating artificial red blood cells by encapsulating hemoglobin with membranes formed from synthetic polymers (e.g. pyroxylin, cellulose nitrate, polystyrene, nylon, silicone rubber, and polyamide). Membranes have also been prepared using lipids, combinations of lipids with proteins, and cholesterol. Cross-linked hemoglobin can be achieved chemically or genetically. Chemically cross-linked hemoglobin involves the use of cross-linking agents, such as diacids and dialdehydes that bind amine groups on the exterior of the hemoglobin molecule to form polyhemoglobin. Alternatively, hemoglobin may he genetically engineered to produce a functional, membrane-free hemoglobin tetramer that will not dissociate into toxic dimers. 2. Perfluorinated compounds Emulsions of perfluorinated compounds called perfluorochemicals, are synthetic compounds made from carbon. Perfluorocarbons are organic compounds that have hydrogen atoms replaced with fluorine [(C[F.sub.2]).sub.n] and can dissolve 50 percent or more of their own volume of oxygen. In the mid-1960s, Clark and Gollan (Science, 1966, 152:1755-1756) demonstrated the ability of mice to breathe while immersed in liquid fluorocarbon. Perfluorocarbons can: * transport oxygen and other respiratory gases; * be produced on an industrial scale; * be stored indefinitely; * be easily sterilized to prevent disease transmission. Furthermore, perfluorocarbons are useful as artificial blood for patients whose cultural/religious beliefs do not allow the use of animal blood products. 3. Transgenic hemoglobin The production of human hemoglobin has been accomplished through recombinant technology using microorganisms (e.g. E. coli or yeast), transgenic plants (e.g. tobacco) or animals. For example, recombinant human hemoglobin has been produced in E. coli and S. cerevisiae using an expression vector containing two mutant human hemoglobin genes. Human hemoglobin has also been produced in transgenic mice and pigs using human hemoglobin gene constructs that are injected into fertilized eggs and the embryo developed in a surrogate mother. Another new development has been the extraction of hemoblogin from the earthworm and the common marine worm for testing as possible blood substitutes. Patent system and interdisciplinary technologies Innovative approaches to developing a potential blood substitute involves expertise in any combination of biotechnology, physiology, biophysics, biochemistry, chemical engineering, enzyme engineering, biomedical engineering, genetic engineering, clinical medicine, chemistry, and polymer chemistry. Ironically, however, the interdisciplinary nature of an innovative technology creates problems for a patent office in securing a patent. Not only does a combination of disciplines require a patent office to decide on the best way to classify and examine these patent applications, but it also requires finding examiners capable of understanding such inventions. As such, patent examiners may not have experience in a particular interdisciplinary technology, which requires a person to step outside of the confines of a single scientific discipline. Novelty One of the basic legal requirements for obtaining a patent is that the invention must be novel over the prior art. As such, the quality of searching by the patent office is extremely important in assessing the novelty of an invention. However, identifying relevant prior art in an interdisciplinary technology can be difficult for an examiner because the technology is new and bridges a range of scientific disciplines and fields of applications. As such, a single examiner or technology group may be insufficient to determine the novelty of the invention. Non-obviousness www.entrepreneur.com/tradejournals/article/157588720.html
|
|
|
Post by aqt on Aug 25, 2009 16:47:41 GMT -5
www.bio-medicine.org/medicine-news/Scientists-in-Britain-Create-Artificial-Blood-21857-1/potential for this product and about the fact that this could save lives, said Lance Twyman of the university's Department of Chemistry. "Many people die from superficial wounds when they are trapped in an accident or are injured in the battlefield and can't get blood before they get to hospital. "This product can be stored a lot more easily than blood, meaning large quantities could be carried easily by ambulances and the armed forces." A sample of the artificial blood prototype will be on display at the Science Museum in London from May 22 as part of an exhibition about the history of plastics. plastics? aqt
|
|
|
Post by aqt on Aug 25, 2009 16:48:53 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 16:52:20 GMT -5
www.wipo.int/pctdb/en/wo.jsp?wo=2002087540ARTIFICIAL BLOOD MADE OF HEMOGLOBIN ENCAPSULATED IN LIPOSOMES The process is suitable for producing liposomes suitable to be used as artificial blood made from haemoglobin and from lipoids in organisms of vertebrata. The particles of smaller size than genuine blood-cells (200-500nm) are suitable for substituting the function of gas supply of red blood-cells. Production of artificial blood particles can take place with using haemoglobin of congener or foreign type. aqt
|
|
|
Post by aqt on Aug 25, 2009 16:55:35 GMT -5
www.patentgenius.com/patent/4443480.htmlArtificial blood and other gas transport agents A number of years ago, the oxygen carrying capacity and lack of toxicity of perfluorinated liquids were reported. Emulsions of fluorocarbon liquids were also used as artificial bloods. In brief, over nearly the last 20 years, considerable workhas been accomplished in connection with the use of fluorocarbons and fluorocarbon emulsions as oxygen transfer agents and as artificial bloods. Artificial bloods are now being commercialized, particularly in foreign countries where the requirements fortheir use and commercialization are not as involved as they are here in the United States.
|
|
|
Post by aqt on Aug 25, 2009 16:56:58 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 16:59:12 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 17:00:51 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 17:07:16 GMT -5
www.fiercebiotechresearch.com/story/penn-protein-may-open-path-artificial-blood/2009-03-31Penn protein may open path to artificial blood Scientists at Penn have built a protein from scratch that can carry oxygen, a big step toward creating artificial blood. And in a key breakthrough, the proteins they have built are waterproof, which prevents cellular damage. "I think it's a notable achievement in protein design," Roman Boulatov, an assistant professor of chemistry at the University of Illinois at Urbana-Champaign, tells MIT Technology Review. "They show it's possible to engineer a specific reactivity by starting from scratch. It gives you much more control over what you can change." "There's a problem working with natural proteins in that they're complex and fragile," says Christopher Moser, coauthor of the study. " We'd like to learn how to make functional proteins that are completely unrelated to natural proteins: that will allow us to continue to build more features." aqt
|
|
|
Post by aqt on Aug 25, 2009 17:09:14 GMT -5
stem-cell-authority.com/46/uk-project-to-create-artificial-blood/An Amercian company called Advanced Cell Technology has done some work in this field but was stymied in part by the US ban on stem cell research which was recently rescinded by President Obama. The scientists at Advanced Cell Technology demonstrated that it was possible to make up to 100 billion red blood cells but this is still below the 5 trillion red blood cells that are present in a liter of donated blood. you don't say? aqt
|
|
|
Post by aqt on Aug 25, 2009 17:12:04 GMT -5
|
|
|
Post by aqt on Aug 25, 2009 17:13:47 GMT -5
|
|
|
Post by skyship on Aug 25, 2009 18:49:00 GMT -5
Can these blood cells be formed from "light scattering particles"? I am starting to think so. However, here they talk of "reverse light scattering" ======================================= "Characterization of spherical particles using high-order neural networks and scanning flow cytometry Vladimir V. Berdnika, Konstantin Gilevb, Alexander Shvalovc, d, Valeri Maltsevc, d and Valery A. Loikoe, Corresponding Author Contact Information, E-mail The Corresponding Author aInstitute for Aerospace technology, Lipatov str., 2, 420075 Kazan, Russia bSobolev Institute of Mathematics, Siberian Branch of the Russian Academy of Sciences, 4 Acad. Koptyug avenue, 630090 Novosibirsk, Russia cNovosibirsk State University, Pirogova Str. 2, 630090 Novosibirsk, Russia dInstitute of Chemical Kinetics and Combustion, Siberian Branch of the Russian Academy of Sciences, Institutskaya Str. 3, 630090 Novosibirsk, Russia eB.I. Stepanov Institute of Physics of the National Academy of Sciences of Belarus, F. Scaryna avenue, 68, 220072 Minsk, Belarus Abstract We retrieve the radius R, real n and imaginary k parts of the refractive index of homogeneous spherical particles using angular distribution of the light-scattering intensity. To solve the inverse light-scattering problem we use a high-order neural-network technique. The effect of network parameters on optimization is examined. The technique is evaluated for noise-corrupted input data at 0.6 μm<R<10.6 μm, 1.02<n<1.38, and 0<k<0.03. The errors of retrieval for nonabsorbing particles do not exceed 0.05 μm for radius and 0.015 for refractive index. The experimental verification is fulfilled by experimental data retrieved by means of a scanning flow cytometer. The light-scattering profiles of polystyrene beads and spherized red blood cells are processed with the high-order neural networks and a non-linear regression at Mie theory. The parameters retrieved by the high-order neural networks correlate well with the parameters retrieved by the least-square method. Keywords: Neural networks; Particle sizing; Inverse light scattering problem" tinyurl.com/mu6kl8================================================ Rayleigh-Gans-Debye and Mie theories in the determination of spherical particle sizes B. R. Jennings and H. G. Jerrard Department of Physics, Southampton University, Southampton, England Abstract The results of a light scattering study of four rubber latex samples using a dissymmetry technique are reported. Particle diameters found from the Rayleigh-Gans-Debye and Mie theories were in the range 1,400 to 2,000 A. In water the relative refractive index of these particles was m = 1.15 so that for particles of this size, the two accepted theoretical limitations for the RGD theory were exceeded. However, the results indicate that this theory can still be used to give particle sizes to within 5% for values of m approaching 1.15 and for diameters of up to 2,000 A. tinyurl.com/nta5zm=========================================== Swelling of latex particles Maurice Morton, Samuel Kaizerman and Mary W. Altier Rubber Research Laboratory, University of Akron, Akron, Ohio, USA Abstract A theoretical relation has been derived for the equilibrium swelling of latex particles. The equilibrium solubility and rate of solution of solvents were measured on a series of polystyrene latex fractions of varying particle size. The solvents used were styrene, toluene, and chlorocyclohexane. It was found, as predicted by theory, that the equilibrium amount of solvent imbibed by latex particles is a direct function of the particle diameter and an inverse function of the interfacial energy at the surface of the particles. The molecular weight of the polymer has no effect on the equilibrium swelling, within the range from 100,000 to several million molecular weight units. The rate of imbibition of these solvents appears to be extremely rapid, indicating that equilibrium solubility would appear to be maintained in most polymerization reactions. The fact that a particular solvent is a “good” solvent for the polymer does not necessarily result in a greater swelling of the particles, since the solvent may show a higher interfacial energy against the aqueous phase. The soap titration method is best for determining the average particle size of a latex for purposes of predicting equilibrium swelling. =========================================== ======================== Now, are these artificial blood cells made from latex? seems the polystyrene particle spheres can be controlled by light scattering techniques, or wave action as in light waves, rather than micro wave or radio wave. ===================== above, mentions the rubber....... so they almost admit here that they are doing this from particulate matter, at nano level. so, this would be why the aerosol operations and the scaler go hand in hand. Light waves through scaler, there is such a thing? First the latex particles as artificial blood cells: Effects of surface charge of polymeric particles on circulation time page 101 found here: tinyurl.com/mlzfbkSure seems to be latex polymeric particles involved here. Too perfect as Mr. Carnicom states. skyship
|
|
|
Post by skyship on Aug 25, 2009 19:06:39 GMT -5
Keep an eye on this DooLittle................. have come across that name numerous times. Now, this may explain how it is done. This is complicated, but they are talking about Synthetic peptides here in the fibrin, (part of blood), and fibrinogen. A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides Abstract A blood clot is a meshwork of fibrin fibers built up by the systematic assembly of fibrinogen molecules proteolyzed by thrombin. Here, we describe a model of how the assembly process occurs. Five kinds of interaction are explicitly defined, including two different knob–hole interactions, an end-to-end association between γ-chains, a lateral association between γ-chains, and a hypothetical lateral interaction between β-chains. The last two of these interactions are responsible for protofibril association and are predicated on intermolecular packing arrangements observed in crystal structures of fibrin double-D fragments cocrystallized with synthetic peptides corresponding to the knobs exposed by the release of the fibrinopeptides A and B. Keywords: blood clots, crystal packing, protofibrils, macromolecular assembly www.pubmedcentral.nih.gov/articlerender.fcgi?artid=18887skyship
|
|
|
Post by skyship on Aug 25, 2009 20:52:12 GMT -5
Aqt, protofibril: mmmmmmmmm lithostathine protofibril what is this? check out the fibers in air etc. and the particles in the lower left photo: ......"Morphological characterization of lithostathine protofibrils by tapping mode AFM in air (A–D) and in solution (E). The S1 form of lithostathine polymerizes into protofibrils (A) that can form networks "........... www.nature.com/emboj/journal/v20/n13/fig_tab/7593829f1.html================= When they say tapping mode, by woodpecker? mmmmmmmmm scaler? or particle? light scattering? lithostathine: the stone PROTEIN in pancreatitis. wow! www.copewithcytokines.de/cope.cgi?key=Lithostathineand the connection to Alzheimers? blood? Above may not apply to fibrins though. but, this will: POLYHEME found lab that makes it> Northfield Labs How it is made: www.northfieldlabs.com/process.htmldoesn't tell us what the polyheme is made of though. maybe this will: Poly SFH-P and it can carry UNIVERSAL O BLOOD......that is what they are aiming for is one blood type amongst all humans. Poly SFH-P: Some concerns .... no public consent here....... www.bioethics.iu.edu/body.cfm?id=80skyship skyship
|
|
bannannas
New Member
Whoever said a FIBER diet was good for you?
Posts: 30
|
Post by bannannas on Aug 31, 2009 17:18:10 GMT -5
Do you guys think morgs is replicating our blood too... therefore leaving us with artificial blood? Is that even a possibility? You know I don't understand all the scientific jargon.... so just wondering!
How ya doin sky? Good I hope!
hugs ~~ bannannas
|
|
|
Post by mfromcanada on Aug 31, 2009 18:12:04 GMT -5
I think that morgellons is in our blood but not replicating it. I think it is thickening our blog, like clotting. I also think that morgellons is in our lymph. Many of the symptoms of morgellons are similar to diseases/problems with the lymphatic system. I think we have a type of slime mold that is in our blood and our lymph. That is why is causes systemic illness.
|
|
|
Post by skyship on Aug 31, 2009 23:08:24 GMT -5
Banannas, Am thinking to get the universal O blood, for everyone, an artificial blood has been produced, however, in Morgellons our blood as another component, the spheres are too perfect, not normal, hence artificial O, replacing our A and B blood. By use of viral component, bacteriophages, these viral particles can enter blood cells, just as in the iridoviral component in the snake blood, in detail on the crystal thread........... I am looking at the sphere, which can be formed from a bacteriophage, not all are, but certain ones can be. So, the iridovirus is what? ====================================== Here is bees it is called Iridescent virus: same thing, SAME HEXAGONAL FORM: vir.sgmjournals.org/cgi/reprint/31/3/459.pdfthis is important....................... Here is another repeat of the blood substitues: ===================================== "Blood substitutes (also called artificial blood or blood-surrogates) are used to fill fluid volume and/or carry oxygen and other blood gases in the cardiovascular system. Although commonly used, the term is not accurate since human blood performs many important functions which blood substitutes may not. Red blood cells transport oxygen, white blood cells defend against disease, platelets promote clotting, and plasma proteins perform various functions. The preferred and more accurate terms are volume expanders for inert products, and oxygen therapeutics for oxygen-carrying products. Examples of these two "blood substitute" categories: * Volume expanders: inert and merely increase blood volume. These may be crystalloid-based (Ringer's lactate, normal saline, D5W (dextrose 5% in water) or colloid-based (Voluven, Haemaccel, Gelofusin). * Oxygen therapeutics: mimic human blood's oxygen transport ability. Examples: Hemopure, Oxygent, PolyHeme and Perftoran. Oxygen therapeutics are in turn broken into two categories based on transport mechanism: perfluorocarbon based, and hemoglobin based. Volume expanders are widely available and are used in both hospitals and first response situations by paramedics and emergency medical technicians. Oxygen therapeutics are in clinical trials in the U.S. and Europe, however Hemopure is more widely available in South Africa. en.wikipedia.org/wiki/Blood_substitutesskyship here is shows can be done in crystalline form: "Volume expanders: inert and merely increase blood volume. These may be crystalloid-based (Ringer's lactate, normal saline, D5W (dextrose 5% in water) or colloid-based (Voluven, Haemaccel, Gelofusin)."
|
|
|
Post by skyship on Aug 31, 2009 23:49:27 GMT -5
Voluven Haemaccel Gelofusin what are these made of? voluven: english.pravda.ru/news/world/29-12-2007/103258-blood_substitute-0note perfect formations........OHOH used in oil drilling as well. je wizz..... Haemaccel: Haemaccel From Wikipedia, the free encyclopedia Jump to: navigation, search A type of intravenous colloid used in the prevention or treatment of shock associated with reduction in effective circulating blood volume due to hemorrhage, loss of plasma (burns, peritonitis, pancreatitis, crush injuries), or loss of water and electrolytes from persistent vomiting and diarrhea. Haemaccel contains degraded gelatin. Haemaccel (also marketed as Emagel in Italy and Solucel in Venezuela) was originally brought to market by Sanofi-Aventis, and later acquired by Nicholas_Piramal. en.wikipedia.org/wiki/Haemaccelskyship
|
|
|
Post by crystalriver on Sept 1, 2009 9:45:40 GMT -5
The blood is the key and skyship is correct but more focus on the Rh negative is needed--that is what is special about our blood the Rh negative.
Even if you have a postitive blood type it is most likely one of your parents carry the silent allele for the Rh negative.
This is what they have had problems copying--the Rh negative.
Everything has been done to take away our credibility before we began to speak. The DOP is a perfect example of this--they knew about us before we knew about us.
They set the stage for our defeat but they forgot something-- the will of God is with us--we must keep going.
The Rh negative persons of the planet have been tracked since birth why do you think that is?
|
|
|
Post by aqt on Sept 11, 2009 10:25:06 GMT -5
I think the Rh negative people of the world are the original "beings"
what say you?
aqt
|
|
jonsi
Full Member
Posts: 111
|
Post by jonsi on Sept 12, 2009 2:58:34 GMT -5
mfromcanada wrote: "I think that morgellons is in our blood but not replicating it. I think it is thickening our blog, like clotting. I also think that morgellons is in our lymph. Many of the symptoms of morgellons are similar to diseases/problems with the lymphatic system. I think we have a type of slime mold that is in our blood and our lymph. That is why is causes systemic illness."www.accelerated-wellness.com/lymph-drainage.htm One thing that helped me to better health is lymphatic massage (lymph star electicic wands). 2 1/2 years ago I got a massage every week. Then I went every two weeks, then every three weeks. My lymphatic therapist also practices reiki. www.reiki.org/faq/WhatIsReiki.htmlI am not a scientist... I just want to help others find their path to better health! Peace, love to all, ~jonsi
|
|